InvestorsHub Logo

AVII77

11/10/19 12:58 PM

#224098 RE: Whalatane #224065

So for the primary diabetic population ..at 12% RRR ...benefits still far out weigh risks and IMHO will be included ...altho I expect it to be debated .


And let's not forget the 19% RRR in Hard MACE in that same primary prevention (diabetic w/ risk factor) population.